Skip to main content
DT

Day Three Labs

Day Three Labs has developed Unlokt, a proprietary infusion technology that enhances bioavailability by up to three times compared to traditional methods while ensuring precise dosing of active pharmaceutical ingredients. This technology addresses the challenges of stability and degradation in infused products, enabling consistent and controlled experiences with clean, all-natural ingredients.

Denver, United StatesFounded 2020
Updated 4 months ago

Funding

$13.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Traditional infusion methods for active pharmaceutical ingredients (APIs) often suffer from poor bioavailability, inconsistent dosing, and degradation of delicate compounds, leading to unpredictable product experiences. Existing nano-emulsion technologies can be unstable and may not efficiently deliver the desired API payload into circulation.

Solution

Day Three Labs has developed Unlokt, a patented infusion technology that enhances API bioavailability by up to three times compared to conventional methods. Unlokt ensures precise dosing of APIs in desired ratios, resulting in consistent and controlled product experiences. The technology increases API stability, preventing degradation and preserving delicate compounds. Unlokt bypasses first-pass metabolism, delivering a higher payload into circulation, and boasts a high loading capacity without solubility loss.

Target Audience

The primary customers are manufacturers of infused products in the pharmaceutical, nutraceutical, and food industries seeking to improve the bioavailability, stability, and dosing precision of their API formulations.

Features

  • Up to 3x greater bioavailability compared to traditional infusion methods, as demonstrated in pharma-model PK trials
  • Pharmaceutical-grade precision in API dosing for consistent and predictable experiences
  • Input agnostic, compatible with full-spectrum extracts and isolates
  • Increased API shelf-life, with accelerated stability studies showing under 10% degradation after 18 months
  • Composed of clean, all-natural, food-grade ingredients (protein and API) without added chemicals or masking agents
  • Available in both liquid and powder forms for versatile incorporation into gummies, tablets, softgels, and other product formats
This profile is AI-generated and may contain inaccuracies.